AWS for Industries
2024 – The Year of Production | Highlights from the AWS Life Sciences Leaders Symposium 2024
Last week, we hosted our 6th Annual AWS Life Sciences Leaders Symposium in Boston. Over 450 executives from 240 top life sciences organizations joined us in person for an intense full-day discussion on how life sciences organizations can leverage generative AI, machine learning, and data analytics on AWS to revolutionize drug discovery and clinical development. […]
Transforming Patient Care: Generative AI Innovations in Healthcare and Life Sciences (Part 1)
As early adopters of artificial intelligence (AI), healthcare and life science organizations are among the most enthusiastic and advanced users of generative AI. The transformative technology has undergone a remarkable evolution in the past year, propelling innovations once considered science fiction into reality – with the potential to transform these industries and significantly improve patient outcomes […]
Key takeaways from Gilead’s Innovation Talk at re:Invent 2023
Contributed by Authors: Marc Berson, Senior Vice President, Chief Information Officer of Gilead Sciences, and Dan Sheeran, General Manager of Healthcare and Life Sciences at AWS. At re:Invent 2023, Marc Berson, Chief Information Officer of Gilead Sciences, joined an Innovation Talk on ‘Generative AI for Industries’, along with Shaown Nandi, AWS Director of Technology for […]
Three Takeaways from Pfizer at AWS re:Invent Keynote
Contributed by Authors: Lidia Fonseca, Chief Digital and Technology Officer of Pfizer, and Dan Sheeran, General Manager of Healthcare and Life Sciences at AWS. Pfizer applies its scientific expertise and global resources to bring vaccines and therapies to people that extend and significantly improve their lives. Last year, Pfizer treated 1.3 billion patients – that’s […]
Bayer Creates Secure Self-Service Solution for Data Scientists on AWS
This blog is guest authored by Dr. Stefan Schmitz, lead product owner of Bayer’s cross-divisional data science platform, and Maciej Wroblewski, AWS architect from the Accenture Advanced Technology Center. Leading global life sciences organization Bayer has more than 150 years of history and expertise in health care and agriculture. To accelerate the adoption of advanced […]
BioT Builds Cloud-Native Medical Devices on AWS
Blog is guest authored by Guy Vinograd, Co-founder and Chief Technology Officer at BioT. With a vision to make world-class medical care accessible to patients wherever they are, Israeli startup BioT provides a platform for building cloud-powered medical devices. Its innovative technology helps connect Internet of Things (IoT) medical devices to the cloud. This allows […]
2023: a turning point for ML in life sciences
To our many customers and partners who work in Life Sciences, welcome to 2023, a year that I expect to be the turning point in how data science and machine learning (ML) accelerate development of new life-saving therapies. (I’ll share 2023 thoughts on Healthcare in an upcoming post.) The first reason I’m so optimistic is […]
MSD Builds HawkAVI Platform on AWS to Reduce Product Reject Rates
Blog is guest authored by Nitin Kaul and Guglielmo Iozzia of Merck & Co., Inc. Improving the productivity of manufacturing operations is vital for pharmaceutical companies, so patients can get the critical medicines they need, faster. While patient safety has always been the highest priority, Merck & Co., Inc. (MSD), the leading global biopharmaceutical company, […]
Bristol Myers Squibb Deploys Accounts from Multiverse Solution within an hour Using AWS Control Tower
Blog Guest authored by HonChong Chang, Director of Cloud & Devops at Bristol Myers Squibb With operations spread across five continents, global biopharmaceutical company Bristol Myers Squibb’s (BMS) cloud team had too much on their plate serving its multi-account, multi-region project teams, without enough resources or hours in the day. Manual workflows for incoming requests […]
Roche advances personalized healthcare using multi-modal data on AWS
Blog guest-authored by Mustaqhusain Kazi, Global Head of Roche Informatics Strategy and Digital Innovation, and Neeraj Agarwal, Distinguished Enterprise Architect, Foundational Tech, PHC and Science at Roche. In the 1990s, the “blockbuster model” reigned supreme, with pharmaceutical companies designing therapies for larger populations with a one-size-fits-all approach. Today, with increased digitization and an explosion of patient […]









